CLIENT
Sanofi Consumer Healthcare
Alberto Hernandez, Chief Growth Officer, Consumer Healthcare
Jordana Barish, US Portfolio Lead, Pain & Sleep
Danielle Prencipe, Senior Brand Manager
Alex Brumlow, Assistant Brand Lead
Vincent Balagat, Portfolio Lead, US Pain and Sleep
Alec Jentik, Brand Manager
AGENCY
Sandy Greenberg, CEO / Co-Founder
Terri Meyer, CEO / Co-Founder
Todd Condie, Creative Director
Mike Cicale, Creative Director
Tony Scopellito, Managing Director
Lauren Rubenstein, Group Account Director
Tracy Chapman, Director of Strategy
Madison Cameron, Strategy Director
Josh Bablin, Account Supervisor
Mark Carlson, Senior Copywriter
Jessica Sugarman, Senior Art Director
Rachel Park, Account Executive
Daniel Maughan, Producer
Salutem, A Daniel J. Edelman Company
Katie Scrivano, Strategic Planner
Adam Kitzmann, VP Creative Director
Farah Adhi, Senior Vice President
Zac Rybacki, Executive Creative Director
Deborah Lobel, Managing Director
Havas Media
Jenny Gandhi, Supervisor, Digital Investments
Samantha Zegman, Associate Director, Connections Planning
Sarah Higgins, Senior Media Planner, Digital Investments
Katherine Romeo, Associate, Connections Planning
Meghan McGuirk, VP Group Director, Investment
SUMMARY
In 2020, the arrival of formerly RX–only Voltaren blew up the sleepy topical pain relief category. Voltaren’s invasion was particularly disastrous for hopelessly old-fashioned Aspercreme, which was hemorrhaging share at twice the rate of its peers. But this brand refused to go down without a fight.
Thanks to a transformational campaign called “Kick Pain in the Aspercreme,” Aspercreme didn’t just weather the storm, it emerged stronger than ever, achieving the highest-selling weeks in brand history, outpacing category sales growth by nearly double, and halving its gap with the mighty Voltaren.
